- Di processo
- Particular attention will be given in the clinical cases, to patientswith an indication to perform “in-bore” mri-guided prostate biopsy: • pi-rads 3-5 lesions with negative standard and/or fusion ultrasoundguided biopsy; • reclassification biopsy in patients on activesurveillance with suspected clinical-laboratory and/or radiologicalprogression; • patients with suspected mri lesions 8mm in size or withlesions in “difficult” sites (cranial, anterior).
- Professionali
- The scientific event aims to optimize the diagnostic pathway ofprostate cancer through the reasoned use of multiparametric mri (mri-mp) and “in-bore” mri-guided biopsy. The main professionals involved inthe diagnosis and treatment of prostate cancer (radiologist,urologist, radiation oncologist, uropathologist, radiographer) will bethe lecturers of the course. All participants will be provided withworkstations for clinical case review, and will observe an mri-guidedbiopsy of live case first-hands.
- Di sistema
- The clinical cases to be presented as “live cases” will involve patientswith lesions classified with pi-rads category 3-5 in accordance withpi-rads v2.1. After a review of the patients’ mri-mp and clinical historyin the morning session, course participants will be divided into twogroups to observe the mri-guided biopsies of the same patientspresented in the “live cases” session. Other cases will be presentedand reviewed under the guidance of the tutors. The patient’s entirediagnostic process will be reviewed, covering the procession from theinitial request, through clinical findings, radiological examinations,mpmri, biopsy and final outcome.